Lidia Giraudo

701 citations
13 papers · 367 indexed · h-index 10
  • Immunology top 10%
    • Immune Cell Function and Interaction 8
    • Immunotherapy and Immune Responses 7
    • T-cell and B-cell Immunology 2
  • Oncology top 10%
    • CAR-T cell therapy research 12
    • Hematopoietic Stem Cell Transplantation 1
    • Melanoma and MAPK Pathways 2
    • Angiogenesis and VEGF in Cancer 1
    • RNA Interference and Gene Delivery 1

Lidia Giraudo

13 papers receiving 364 citations

Peers

Lidia Giraudo
Comparison fields: 5 of 46
  • Immunology 270
  • Oncology 282
  • Hematology 20
  • Cancer Research 18
  • Molecular Biology 72
Replace Maja Todorovic with:
Maja Todorovic Italy
Ramona Rotolo Italy
Stephanie Mittman United States
Susanna Gallo Italy
Shuntaro Oniki Japan
Franziska Brauneck Germany
Heather Torrey United States
Joyce M. Lubbers Netherlands
Justin Le United States
Soroosh Radfar United States
Lidia Giraudo relative to Maja Todorovic Italy Maja Todorovic's profile →
Citations per field
00.5×2.7×
Maja Todorovic · 1×
Citations per year

Countries citing papers authored by Lidia Giraudo

Since Specialization
Citations

This map shows the geographic impact of Lidia Giraudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Giraudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Giraudo more than expected).

Fields of papers citing papers by Lidia Giraudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Giraudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Giraudo. The network helps show where Lidia Giraudo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lidia Giraudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lidia Giraudo Line = papers co-authored together Lidia Giraudo links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20229
2 20213
3 201830
4 201823
5 201617
6 201523
7 201510
8 20142
9 201410
10 201418
11 201380
12 2012122
13 201220

About Lidia Giraudo

Lidia Giraudo is a scholar working on Immunology, Oncology and Hematology, having authored 13 papers that have together received 367 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (2 papers), Melanoma and MAPK Pathways (2 papers), Angiogenesis and VEGF in Cancer (1 paper), RNA Interference and Gene Delivery (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Immunology (270 citations), Oncology (282 citations) and Hematology (20 citations). Lidia Giraudo has collaborated with scholars based in Italy, Austria and Belarus. Frequent co-authors include Dario Sangiolo, Loretta Gammaitoni, Massimo Aglietta, Valeria Leuci, Giulia Mesiano, Fabrizio Carnevale‐Schianca, Maja Todorovic, Franca Fagioli, Wanda Piacibello and Ramona Rotolo.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026